Schiff, E, Peleg, E, Goldenberg, M, Rosenthal, T, Ruppin, E, Tamarkin, M, Barkai, G, Ben-Baruch, G, Yahal, I, Blankstein, J, et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989;321:351–6.CrossRefGoogle ScholarPubMed

Benigni, A, Gregorini, G, Frusca, T, Chiabrando, C, Ballerini, S, Valcamonico, A, Orisio, S, Piccinelli, A, Pinciroli, V, Fanelli, R, et al. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med 1989;321:357–62.Google Scholar

Quenby, S, Mountfield, S, Cartwright, JE, Whitley, GS, Vince, G. Effects of low-molecular-weight and unfractionated heparin on trophoblast function. Obstet Gynecol 2004;104:354–61.Google Scholar

Han, CS, Mulla, MJ, Brosens, JJ, Chamley, LW, Paidas, MJ, Lockwood, CJ, Abrahams, VM. Aspirin and heparin effect on basal and antiphospholipid antibody modulation of trophoblast function. Obstet Gynecol 2011;118:1021–8.CrossRefGoogle ScholarPubMed

Henderson, JT, Whitlock, EP, O’Connor, E, Senger, CA, Thompson, JH, Rowland, MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: A systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2014;160:695–703.Google Scholar

Bujold, E, Roberge, S, Lacasse, Y, Bureau, M, Audibert, F, Marcoux, S, Forest, JC, Giguere, Y. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010;116:402–14.Google Scholar

Meher, S, Alfirevic, Z. Aspirin for pre-eclampsia: Beware of subgroup meta-analysis. Ultrasound Obstet Gynecol 2013;41:479–85.Google Scholar

Duley, L, Henderson-Smart, DJ, Meher, S, King, JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007, Issue 2. Art. No.: CD004659.Google Scholar

Henderson, JT, Whitlock, EP, O’Conner, E, Senger, CA, Thompson, JH, Rowland, MG. Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 112. AHRQ Publication No. 14-05207-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2014.Google Scholar

Rolnik, DL, Wright, D, Poon, LC, O’Gorman, N, Syngelaki, A, de Paco Matallana, C, Akolekar, R, Cicero, S, Janga, D, Singh, M, Molina, FS, Persico, N, Jani, JC, Plasencia, W, Papaioannou, G, Tenenbaum-Gavish, K, Meiri, H, Gizurarson, S, Maclagan, K, Nicolaides, KH. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 2017;377:613–622.CrossRefGoogle ScholarPubMed

Askie, LM, Duley, L, Henderson-Smart, DJ, Stewart, LA, Group, PC. Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data. Lancet 2007;369:1791–8.Google Scholar

Roberge, S, Nicolaides, KH, Demers, S, Villa, P, Bujold, E. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: A meta-analysis. Ultrasound Obstet Gynecol 2013;41:491–9.Google Scholar

Ayala, DE, Ucieda, R, Hermida, RC. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol Int 2013;30:260–79.CrossRefGoogle ScholarPubMed

Wojtowicz, A, Undas, A, Huras, H, Musial, J, Rytlewski, K, Reron, A, Wilczak, M, Jach, R. Aspirin resistance may be associated with adverse pregnancy outcomes. Neuro Endocrinol Lett 2011;32:334–9.Google Scholar

Wallenburg, HC, Rotmans, N. Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole. Am J Obstet Gynecol 1987;157:1230–5.Google Scholar

CLASP: A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 1994;343:619–29.Google Scholar

McParland, P, Pearce, JM, Chamberlain, GV. Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension. Lancet 1990;335:1552–5.Google Scholar

Viinikka, L, Hartikainen-Sorri, AL, Lumme, R, Hiilesmaa, V, Ylikorkala, O. Low dose aspirin in hypertensive pregnant women: Effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn. BJOG 1993;100:809–15.Google Scholar

Caspi, E, Raziel, A, Sherman, D, Arieli, S, Bukovski, I, Weinraub, Z. Prevention of pregnancy-induced hypertension in twins by early administration of low-dose aspirin: A preliminary report. Am J Reprod Immunol 1994;31:19–24.CrossRefGoogle Scholar

Hermida, RC, Ayala, DE, Iglesias, M, Mojon, A, Silva, I, Ucieda, R, Fernandez, JR. Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women. Hypertension 1997;30:589–95.CrossRefGoogle ScholarPubMed

Caritis, S, Sibai, B, Hauth, J, Lindheimer, MD, Klebanoff, M, Thom, E, Van Dorsten, P, Landon, M, Paul, R, Miodovnik, M, Meis, P, Thurnau, G. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998;338:701–5.CrossRefGoogle ScholarPubMed

Vainio, M, Kujansuu, E, Iso-Mustajarvi, M, Maenpaa, J. Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG 2002;109:161–7.Google ScholarPubMed

Yu, CK, Papageorghiou, AT, Parra, M, Palma, Dias, R, Nicolaides, KH, Fetal Medicine Foundation Second Trimester Screening G. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks’ gestation. Ultrasound Obstet Gynecol 2003;22:233–9.Google Scholar

Villa, PM, Kajantie, E, Raikkonen, K, Pesonen, AK, Hamalainen, E, Vainio, M, Taipale, P, Laivuori, H, Group, PS. Aspirin in the prevention of pre-eclampsia in high-risk women: A randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials. BJOG 2013;120:64–74.Google Scholar

Kingdom, JC, Walker, M, Proctor, LK, Keating, S, Shah, PS, McLeod, A, Keunen, J, Windrim, RC, Dodd, JM. Unfractionated heparin for second trimester placental insufficiency: A pilot randomized trial. J Thromb Haemost 2011;9:1483–92.CrossRefGoogle ScholarPubMed

Kupferminc, M, Rimon, E, Many, A, Maslovitz, S, Lessing, JB, Gamzu, R. Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia. Blood Coagul Fibrinolysis 2011;22:123–6.Google Scholar

Duffett, L, Rodger, M. LMWH to prevent placenta-mediated pregnancy complications: An update. Br J Haematol 2014.Google Scholar

Greer, IA, Brenner, B, Gris, JC. Antithrombotic treatment for pregnancy complications: Which path for the journey to precision medicine? Br J Haematol 2014;165:585–99.Google Scholar

Dodd, JM, McLeod, A, Windrim, RC, Kingdom, J. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. Cochrane Database Sys Rev 2013, Issue 7. Art. No.: CD006780.Google Scholar

Rodger, MA, Carrier, M, Le Gal, G, Martinelli, I, Perna, A, Rey, E, De Vries, JI, Gris, JC, Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study G. Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications. Blood 2014;123:822–8.Google Scholar

Rodger, MA, Hague, WM, Kingdom, J, Kahn, SR, Karovitch, A, Sermer, M, Clement, AM, Coat, S, Chan, WS, Said, J, Rey, E, Robinson, S, Khurana, R, Demers, C, Kovacs, MJ, Solymoss, S, Hinshaw, K, Dwyer, J, Smith, G, McDonald, S, Newstead-Angel, J, McLeod, A, Khandelwal, M, Silver, RM, Le Gal, G, Greer, IA, Keely, E, Rosene-Montella, K, Walker, M, Wells, PS, Investigators, T. Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial. Lancet 2014;384:1673–83.CrossRefGoogle Scholar

Mello, G, Parretti, E, Fatini, C, Riviello, C, Gensini, F, Marchionni, M, Scarselli, GF, Gensini, GF, Abbate, R. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension 2005;45:86–91.CrossRefGoogle ScholarPubMed

Rey, E, Garneau, P, David, M, Gauthier, R, Leduc, L, Michon, N, Morin, F, Demers, C, Kahn, SR, Magee, LA, Rodger, M. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: A pilot randomized controlled trial. J Thromb Haemost 2009;7:58–64.Google Scholar

Gris, JC, Chauleur, C, Molinari, N, Mares, P, Fabbro-Peray, P, Quere, I, Lefrant, JY, Haddad, B, Dauzat, M. Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial. Thromb Haemost 2011;106:1053–61.Google Scholar

De Vries, JI, Van Pampus, MG, Hague, WM, Bezemer, PD, Joosten, JH, Investigators, F. Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: The FRUIT-RCT. J Thromb Haemost 2012;10:64–72.CrossRefGoogle ScholarPubMed

Martinelli, I, Ruggenenti, P, Cetin, I, Pardi, G, Perna, A, Vergani, P, Acaia, B, Facchinetti, F, La Sala, GB, Bozzo, M, Rampello, S, Marozio, L, Diadei, O, Gherardi, G, Carminati, S, Remuzzi, G, Mannucci, PM, Group, HS. Heparin in pregnant women with previous placenta-mediated pregnancy complications: A prospective, randomized, multicenter, controlled clinical trial. Blood 2012;119:3269–75.CrossRefGoogle ScholarPubMed

Greer, IA, Nelson-Piercy, C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: A systematic review of safety and efficacy. Blood 2005;106:401–7.CrossRefGoogle ScholarPubMed

Casele, H, Haney, EI, James, A, Rosene-Montella, K, Carson, M. Bone density changes in women who receive thromboprophylaxis in pregnancy. Am J Obstet Gynecol 2006;195:1109–13.CrossRefGoogle ScholarPubMed

Kaufmann, P, Black, S, Huppertz, B. Endovascular trophoblast invasion: Implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003;69(1):1–7.CrossRefGoogle ScholarPubMed

Myatt, L. Review: Reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta 2010;31 Suppl:S66–69.Google Scholar

Krause, BJ, Hanson, MA, Casanello, P. Role of nitric oxide in placental vascular development and function. Placenta 2011;32(11):797–805.Google Scholar

De Pace, V, Chiossi, G, Facchinetti, F. Clinical use of nitric oxide donors and L-arginine in obstetrics. J Matern Fetal Neonatal Med 2007;20(8):569–79.CrossRefGoogle ScholarPubMed

Govers, R, Rabelink, TJ. Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol 2001;280(2):F193–206.Google Scholar

Lowe, DT. Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide 2000;4(4):441–58.Google Scholar

Bird, IM, Zhang, L, Magness, RR. Possible mechanisms underlying pregnancy-induced changes in uterine artery endothelial function. Am J Physiol Regul Integr Comp Physiol 2003;284(2):R245–58.Google Scholar

Johnson, MR, Anim-Nyame, N, Johnson, P, Sooranna, SR, Steer, PJ. Does endothelial cell activation occur with intrauterine growth restriction? BJOG 2002;109(7):836–9.CrossRefGoogle ScholarPubMed

Pisaneschi, S, Strigini, FA, Sanchez, AM, Begliuomini, S, Casarosa, E, Ripoli, A, Ghirri, P, Boldrini, A, Fink, B, Genazzani, AR, Coceani, F, Simoncini, T. Compensatory feto-placental upregulation of the nitric oxide system during fetal growth restriction. PLoS One 2012;7(9):e45294.Google Scholar

Meher, S, Duley, L. Nitric oxide for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007;(2):CD006490.Google Scholar

Mills, TA, Wareing, M, Bugg, GJ, Greenwood, SL, Baker, PN. Chorionic plate artery function and Doppler indices in normal pregnancy and intrauterine growth restriction. Eur J Clin Invest 2005;35(12):758–64.CrossRefGoogle ScholarPubMed

Sweeney, M, Wareing, M, Mills, TA, Baker, PN, Taggart, MJ. Characterisation of tone oscillations in placental and myometrial arteries from normal pregnancies and those complicated by pre-eclampsia and growth restriction. Placenta 2008;29(4):356–65.CrossRefGoogle ScholarPubMed

Wu, G, Bazer, FW, Satterfield, MC, Li, X, Wang, X, Johnson, GA, Burghardt, RC, Dai, Z, Wang, J, Wu, Z. Impacts of arginine nutrition on embryonic and fetal development in mammals. Amino Acids 2013;45(2):241–56.Google Scholar

Neri, I, Mazza, V, Galassi, MC, Volpe, A, Facchinetti, F. Effects of L-arginine on utero-placental circulation in growth-retarded fetuses. Acta Obstet Gynecol Scand 1996;75:208–12.Google Scholar

Neri, I, Marietta, M, Piccinini, F, Volpe, A, Facchinetti, F. The L-arginine-nitric oxide system regulates platelet aggregation in pregnancy. J Soc Gynecol Invest 1998;5(4):192–6.Google Scholar

Sieroszewski, P, Suzin, J, Karowicz-Bilińska, A. Ultrasound evaluation of intrauterine growth restriction therapy by a nitric oxide donor (L-arginine). J Matern Fetal Neonatal Med 2004;15(6):363–6.Google Scholar

Xiao, XM, Li, LP. L-arginine treatment for asymmetric fetal growth restriction. Int J Gynaecol Obstet 2005;88(1):15–18.Google Scholar

Winer, N, Branger, B, Azria, E, Tsatsaris, V, Philippe, HJ, Rozé, JC, Descamps, P, Boog, G, Cynoper, L, Darmaun, D. L-arginine treatment for severe vascular fetal intrauterine growth restriction: A randomized double-bind controlled trial. Clin Nutr 2009;28(3):243–8.Google Scholar

Ramsay, B, de Belder, A, Campbell, S, Moncada, S, Martin, JF. A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of pre-eclampsia. Eur J Clin Invest 1994;24(1):76–8.Google Scholar

Kähler, C, Schleussner, E, Möller, A, Seewald, HJ. Nitric oxide donors: Effects on fetoplacental blood flow. Eur J Obstet Gynecol Reprod Biol 2004;115(1):10–14.Google Scholar

Lees, C, Valensise, H, Black, R, Harrington, K, Byiers, S, Romanini, C, Campbell, S. The efficacy and fetal-maternal cardiovascular effects of transdermal glyceryl trinitrate in the prophylaxis of pre-eclampsia and its complications: A randomized double-blind placebo-controlled trial. Ultrasound Obstet Gynecol 1998;12(5):334–8.Google Scholar

Barsoum, IB, Renaud, SJ, Graham, CH. Glyceryl trinitrate inhibits hypoxia-induced release of soluble fms-like tyrosine kinase-1 and endoglin from placental tissues. Am J Pathol 2011;178(6):2888–96.Google Scholar

Schleussner, E, Lehmann, T, Kähler, C, Schneider, U, Schlembach, D, Groten, T. Impact of the nitric oxide-donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: A prospective, randomized, double-blinded trial. J Perinat Med 2014;42(4):507–14.Google Scholar

Daiber, A, Wenzel, P, Oelze, M, Münzel, T. New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance. Clin Res Cardiol 2008;97(1):12–20.CrossRefGoogle ScholarPubMed

Read, MA, Giles, WB, Leitch, IM, Boura, AL, Walters, WA. Vascular responses to sodium nitroprusside in the human fetal-placental circulation. Reprod Fertil Dev 1995;7(6):1557–61.Google Scholar

Koopmans, CM, Blaauw, J, Van Pampus, MG, Rakhorst, G, Aarnoudse, JG. Abnormal endothelium-dependent microvascular dilator reactivity in pregnancies complicated by normotensive intrauterine growth restriction. Am J Obstet Gynecol 2009;200(1):66.e1–6.Google Scholar

Zoma, WD, Baker, RS, Clark, KE. Effects of combined use of sildenafil citrate (Viagra) and 17beta-estradiol on ovine coronary and uterine hemodynamics. Am J Obstet Gynecol 2004;190(5):1291–7.Google Scholar

Wareing, M, Myers, JE, O’Hara, M, Baker, PN. Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction. J Clin Endocrinol Metab 2005;90(5):2550–5.Google Scholar

Dastjerdi, MV, Hosseini, S, Bayani, L. Sildenafil citrate and uteroplacental perfusion in fetal growth restriction. J Res Med Sci 2012;17(7):632–6.Google Scholar

Miller, SL, Loose, JM, Jenkin, G, Wallace, EM. The effects of sildenafil citrate (Viagra) on uterine blood flow and well being in the intrauterine growth-restricted fetus. Am J Obstet Gynecol 2009;200(1):102.e1–7.CrossRefGoogle ScholarPubMed

Nassar, AH, Masrouha, KZ, Itani, H, Nader, KA, Usta, IM. Effects of sildenafil in Nω-nitro-L-arginine methyl ester-induced intrauterine growth restriction in a rat model. Am J Perinatol 2012;29(6):429–34.Google ScholarPubMed

Ganzevoort, W, Alfirevicz, Z, von Dadelszen, P, Kenny, L, Papageorghiou, A, van Wassenaer-Leemhuis, A, Gluud, C, Mol, BW, Baker, PN. STRIDER: Sildenafil Therapy In Dismal prognosis Early-onset intrauterine growth Restriction – a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis. Syst Rev 2014;3:23.Google Scholar

Khong, TY, De Wolf, F, Robertson, WB, Brosens, I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. BJOG 1986;93:1049–59.Google Scholar

Roberts, JM, Taylor, RN, Musci, TJ, Rodgers, GM, Hubel, CA, McLaughlin, MK. Preeclampsia, an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200–4.CrossRefGoogle ScholarPubMed

Taylor, RN, Heilbron, DC, Roberts, JM. Growth factor activity in the blood of women in whom preeclampsia develops is elevated from early pregnancy. Am J Obstet Gynecol 1990;163:1839–44.CrossRefGoogle ScholarPubMed

Roberts, JM, Taylor, RM, Goldfein, A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 1991;4:700–8.CrossRefGoogle ScholarPubMed

Duvekot, JJ, Cheriex, EC, Pieters, FA, Peeters, LH. Severely impaired fetal growth is preceded by maternal hemodynamic maladaptation in very early pregnancy. Acta Obstet Gynecol Scand 1995;74:693–7.Google Scholar

Duvekot, JJ, Cheriex, EC, Pieters, FA, Menheere, PP, Schouten, HJ, Peeters, LH. Maternal volume homeostasis in early pregnancy in relation to fetal growth restriction. Obstet Gynecol 1995;85:361–7.CrossRefGoogle ScholarPubMed

Valensise, H, Vasapollo, B, Novelli, GP, Larciprete, G, Romanini, ME, Arduini, D, Galante, A, Romanini, C. Maternal diastolic function in asyptomatic pregnant women with bilateral notching of the uterine artery waveform at 24 weeks’ gestation. Ultrasound Obstet Gynecol 2001;18:450–5.Google Scholar

Melchiorre, K, Sharma, R, Thilaganathan, B. Cardiovascular implications in preeclampsia: An overview. Circulation 2014;130:703–14.Google Scholar

Valensise, H, Vasapollo, B, Gagliardi, G, Novelli, GP. Early and late preeclampsia: Two different maternal hemodynamic states in the latent phase of the disease. Hypertension 2008;52:873–80.Google Scholar

Vasapollo, B, Novelli, GP, Valensise, H. Total vascular resistance and left ventricular morphology as screening tools for complications in pregnancy. Hypertension 2008;51:1020–6.Google Scholar

Novelli, GP, Valensise, H, Vasapollo, B, Larciprete, G, Altomare, F, Di, Pierro, G, Casalino, B, Galante, A, Arduini, D. Left ventricular concentric geometry as a risk factor in gestational hypertension. Hypertension 2003;41:469–75.Google Scholar

Valensise, H, Vasapollo, B, Novelli, GP, Giorgi, G, Verallo, P, Galante, A, Arduini, D. Maternal and fetal hemodynamic effects induced by nitric oxide donors and plasma volume expansion in pregnancies with gestational hypertension complicated by intrauterine growth restriction with absent end-diastolic flow in the umbilical artery. Ultrasound Obstet Gynecol 2008;31:55–64.Google Scholar

Vasapollo, B, Novelli, GP, Gagliardi, G, Tiralongo, GM, Pisani, I, Manfellotto, D, Giannini, L, Valensise, H. Medical treatment of early-onset mild gestational hypertension reduces total peripheral vascular resistance and influences maternal and fetal complications. Ultrasound Obstet Gynecol 2012;40:325–31.Google Scholar

Melchiorre, K, Sutherland, GR, Liberati, M, Thilaganathan, B. Maternal cardiovascular impairment in pregnancies complicated by severe fetal growth restriction. Hypertension 2012;60:437–43.Google Scholar

Vasapollo, B, Valensise, H, Novelli, GP, Altomare, F, Galante, A, Arduini, D. Abnormal maternal cardiac function precedes the clinical manifestation of fetal growth restriction. Ultrasound Obstet Gynecol 2004;24:23–9.Google Scholar

Berghella, V. Prevention of recurrent fetal growth restriction. Obstet Gynecol 2007;110:904–12.Google Scholar

Grivell, R1, Dodd, J, Robinson, J. The prevention and treatment of intrauterine growth restriction. Best Pract Res Clin Obstet Gynaecol 2009;23:795–807.Google Scholar

Sheridan, C. Intrauterine growth restriction –diagnosis and management. Aust Fam Physician 2005;34:717–23.Google Scholar

Churchill, D, Beevers, GDG, Meher, S, Rhodes, C. Diuretics for preventing pre-eclampsia. Cochrane Database Syst Rev 2007, Issue 1. Art. No.: CD004451.Google Scholar

Sibai, BM, Grossman, RA, Grossman, HG. Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol 1984;150:831–5.Google Scholar

Fortney, SM, Turner, C, Steinmann, RN, Driscoll, CNMT, Alfrey, C. Blood volume responses of men and women to bed rest. J Clin Pharmacol 1994;34:434–9.Google Scholar

Fievet, P, Pleskov, L, Desailly, I, Carayon, A, de Fremont, JF, Coevoet, B, Comoy, E, Demory, JE, Verhoest, P, Boulanger, JC. Plasma renin activity, blood uric acid and plasma volume in pregnancy-induced hypertension. Nephron 1985;40:429–32.CrossRefGoogle ScholarPubMed

Johnson, EC, Muñoz, CX, Le Bellego, L, Klein, A, Casa, DJ, Maresh, CM, Armstrong, LE. Markers of the hydration process during fluid volume modification in women with habitual high or low daily fluid intakes. Eur J Appl Physiol 2015;115:1067–74.Google Scholar

Hofmeyr, GJ, Gülmezoglu, AM. Maternal hydration for increasing amniotic fluid volume in oligohydramnios and normal amniotic fluid volume. Cochrane Database Syst Rev 2002;(1):CD000134.Google Scholar

Flack, NJ, Sepulveda, W, Bower, S, Fisk, NM. Acute maternal hydration in third-trimester oligohydramnios: Effects on amniotic fluid volume, uteroplacental perfusion, and fetal blood flow and urine output. Am J Obstet Gynecol 1995;173:1186–91.Google Scholar

Heyl, W, Boabang, P, Faridi, A, Rath, W. Evaluation of the success of hemodilution therapy for fetal growth retardation by Doppler sonography. Clin Hemorheol Microcirc 1997;17:225–30.Google Scholar

Katz, VL, McMurray, R, Berry, MJ, Cefalo, RC. Fetal and uterine responses to immersion and exercise. Obstet Gynecol 1988;72:225–30.Google Scholar

Thisted, DL, Nørgaard, LN, Meyer, HM, Aabakke, AJ, Secher, NJ. Water immersion and changes in the foetoplacental and uteroplacental circulation: An observational study with the case as its own control. J Matern Fetal Neonatal Med 2014;25:1–5.Google Scholar

Fekete, A, Sasser, JM, Baylis, C. Chronic vasodilation produces plasma volume expansion and hemodilution in rats: Consequences of decreased effective arterial blood volume. Am J Physiol Renal Physiol 2011;300:F113–8.Google Scholar

Lima, MM, Souza, AS, Diniz, C, Porto, AM, Amorim, MM, Moron, AF. Doppler velocimetry of the uterine, umbilical and fetal middle cerebral arteries in pregnant women undergoing tocolysis with oral nifedipine. Ultrasound Obstet Gynecol 2009;34:311–15.Google Scholar

Pivarnik, JM, Mauer, ME, Ayres, NA, Kirshon, B, Dildy, GA, Cotton, DB. Effects of chronic exercise on blood volume expansion and hematologic indices during pregnancy. Obstet Gynecol 1994;83:264–9.Google Scholar

Krause, BJ, Carrasco-Wong, I, Caniuguir, A, Carvajal, J, Farías, M, Casanello, P. Endothelial eNOS/arginase imbalance contributes to vascular dysfunction in IUGR umbilical and placental vessels. Placenta 2013;34:20–8.Google Scholar

Schleussner, E, Lehmann, T, Kähler, C, Schneider, U, Schlembach, D, Groten, T. Impact of the nitric oxide-donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: A prospective, randomized, double-blinded trial. J Perinat Med 2014;42:507–14.Google Scholar

Di Iorio, R, Marinoni, E, Gazzolo, D, Letizia, C, Di, Netta, T, Cosmi, EV. Maternal nitric oxide supplementation increases adrenomedullin concentrations in growth retarded fetuses. Gynecol Endocrinol 2002;16:187–92.Google Scholar

Lees, C, Valensise, H, Black, R, Harrington, K, Byiers, S, Romanini, C, Campbell, S. The efficacy and fetal-maternal cardiovascular effects of transdermal glyceryl trinitrate in the prophylaxis of pre-eclampsia and its complications: A randomized double-blind placebo-controlled trial. Ultrasound Obstet Gynecol 1998;12:334–8.Google Scholar

Spencer, RN, Carr, DJ, David, AL. Treatment of poor placentation and the prevention of associated adverse outcomes – what does the future hold? Prenat Diagn 2014;34:677–84.Google Scholar

Makino, Y, Izumi, H, Makino, I, Shirakawa, K. The effect of nitric oxide on uterine and umbilical artery flow velocity waveform in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 1997;73:139–43.Google Scholar

Martinez-Abundis, E, Gonzalez-Ortiz, M, Hernandez-Salazar, F, Huerta, JLMT. Sublingual isosorbide dinitrate in the acute control of hypertension in patients with severe preeclampsia. Gynecol Obstet Invest 2000;50:39–42.Google Scholar

Manzur-Verastegui, S, Mandeville, PB, Gordillo-Moscoso, A, et al. Efficacy of nitroglycerine infusion versus sublingual nifedipine in severe preeclampsia: A randomized, triple-blind, controlled trial. Clin Exp Pharmacol Physiol 2008;35:580–5.Google Scholar

Aardenburg, R, Spaanderman, ME, Courtar, DA, van Eijndhoven, HW, de Leeuw, PW, Peeters, LL. A subnormal plasma volume in formerly preeclamptic women is associated with a low venous capacitance. J Soc Gynecol Investig 2005;12:107–11.Google Scholar

Herraiz, S, Pellicer, B, Serra, V, Cauli, O, Cortijo, J, Felipo, V, Pellicer, A. Sildenafil citrate improves perinatal outcome in fetuses from pre-eclamptic rats. BJOG 2012;119:1394–402.Google Scholar

Von Dadelszen, P, Dwinnell, S, Magee, LA, Carleton, BC, Gruslin, A, Lee, B, Lim, KI, Liston, RM, Miller, SP, Rurak, D, Sherlock, RL, Skoll, MA, Wareing, MM, Baker, PN; Research into Advanced Fetal Diagnosis and Therapy (RAFT) Group. Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. BJOG 2011;118:624–8.Google Scholar

David, AL, Peebles, D. Gene therapy for the fetus: Is there a future? Best Pract Res Clin Obstet Gynaecol 2008;22(1):203–18.Google Scholar

Mattar, CN, Waddington, SN, Biswas, A, Davidoff, AM, Choolani, M, Chan, JKY, et al. The case for intrauterine gene therapy. Best Pract Res Clin Obstet Gynaecol 2012;26(5):697–709.Google Scholar

Gene Therapy Advisory Committee. Report on the potential use of gene therapy in utero. Health Departments of the United Kingdom, November 1998. Hum Gene Ther 1999;10(4):689–92.Google Scholar

U. S. National Institutes of Health. Recombinant DNA Advisory Committee. Prenatal gene transfer: Scientific, medical, and ethical issues: A report of the Recombinant DNA Advisory Committee. Hum Gene Ther 2000;11(8):1211–29.Google Scholar

Lyall, F, Robson, SC, Bulmer, JN. Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: Relationship to clinical outcome. Hypertension 2013;62(6):1046–54.Google Scholar

Konje, JC, Howarth, ES, Kaufmann, P, Taylor, DJ. Longitudinal quantification of uterine artery blood volume flow changes during gestation in pregnancies complicated by intrauterine growth restriction. BJOG 2003;110(3):301–5.Google Scholar

Ginn, SL, Alexander, IE, Edelstein, ML, Abedi, MR, Wixon, J. Gene therapy clinical trials worldwide to 2012 – an update. J Gene Med 2013;15(2):65–77.Google Scholar

Coutelle, C, Waddington, SN. Vector systems for prenatal gene therapy: Choosing vectors for different applications. Methods Mol Biol 2012;891:41–53.Google Scholar

Khare, R, Chen, CY, Weaver, EA, Barry, MA. Advances and future challenges in adenoviral vector pharmacology and targeting. Curr Gene Ther 2011;11(4):241–58.Google Scholar

Katayama, K, Furuki, R, Yokoyama, H, Kaneko, M, Tachibana, M, Yoshida, I, et al. Enhanced in vivo gene transfer into the placenta using RGD fiber-mutant adenovirus vector Biomaterials 2011;32(17):4185–93.Google Scholar

Al-Hendy, A, Salama, S. Gene therapy and uterine leiomyoma: A review. Hum Reprod Update 2006;12(4):385–400.Google Scholar

Stribley, JM, Rehman, KS, Niu, H, Christman, GM. Gene therapy and reproductive medicine. Fertil Steril 2002;77(4):645–57.Google Scholar

Ahmed, A, Dunk, C, Ahmad, S, Khaliq, A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen – a review. Placenta 2000;21 Suppl A:S16–24.CrossRefGoogle ScholarPubMed

Olsson, AK, Dimberg, A, Kreuger, J, Claesson-Welsh, L. VEGF receptor signalling – in control of vascular function. Nat Rev Mol Cell Biol 2006;7(5):359–71.Google Scholar

Savvidou, MD, Yu, CK, Harland, LC, Hingorani, AD, Nicolaides, KH. Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction. Am J Obstet Gynecol 2006;195(6):1668–73.Google Scholar

Herraiz, I, Droge, LA, Gomez-Montes, E, Henrich, W, Galindo, A, Verlohren, S. Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction. Obstet Gynecol 2014;124(2 Pt 1):265–73.Google Scholar

Roberts, CT, Owens, JA, Sferruzzi-Perri, AN. Distinct actions of insulin-like growth factors (IGFs) on placental development and fetal growth: Lessons from mice and guinea pigs. Placenta 2008;29 Suppl A:S42–7.Google Scholar

Forbes, K, Westwood, M. The IGF axis and placental function. A mini review. Horm Res 2008; 69(3):129–37.Google Scholar

David, AL, Torondel, B, Zachary, I, Wigley, V, Abi-Nader, K, Mehta, V, et al. Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep. Gene Ther 2008;15(19):1344–50.Google Scholar

Mehta, V, Abi-Nader, KN, Peebles, DM, Benjamin, E, Wigley, V, Torondel, B, et al. Long-term increase in uterine blood flow is achieved by local overexpression of VEGF-A(165) in the uterine arteries of pregnant sheep. Gene Ther 2012;19(9):925–35.Google Scholar

Mehta, V, Abi-Nader, KN, Shangaris, P, Shaw, SW, Filippi, E, Benjamin, E, et al. Local over-expression of VEGF-DDeltaNDeltaC in the uterine arteries of pregnant sheep results in long-term changes in uterine artery contractility and angiogenesis. PloS One 2014; 9(6):e100021.Google Scholar

Wallace, JM, Luther, JS, Milne, JS, Aitken, RP, Redmer, DA, Reynolds, LP, et al. Nutritional modulation of adolescent pregnancy outcome – a review. Placenta 2006;27 Suppl A:S61–8.Google Scholar

Robinson, JS, Kingston, EJ, Jones, CT, Thorburn, GD. Studies on experimental growth retardation in sheep. The effect of removal of a endometrial caruncles on fetal size and metabolism. J Dev Physiol 1979; 1(5):379–98.Google Scholar

Wallace, JM, Aitken, RP, Milne, JS, Hay, WW, Jr. Nutritionally mediated placental growth restriction in the growing adolescent: Consequences for the fetus. Biol Reprod 2004;71(4):1055–62.Google Scholar

Wallace, JM, Milne, JS, Matsuzaki, M, Aitken, RP. Serial measurement of uterine blood flow from mid to late gestation in growth restricted pregnancies induced by overnourishing adolescent sheep dams. Placenta 2008;29(8):718–24.Google Scholar

Wallace, JM, Bourke, DA, Aitken, RP, Palmer, RM, Da, Silva, P, Cruickshank, MA. Relationship between nutritionally-mediated placental growth restriction and fetal growth, body composition and endocrine status during late gestation in adolescent sheep. Placenta 2000;21(1):100–8.Google Scholar

Carr, DJ, Aitken, RP, Milne, JS, David, AL, Wallace, JM. Fetoplacental biometry and umbilical artery Doppler velocimetry in the overnourished adolescent model of fetal growth restriction. Am J Obstet Gynecol 2012; 207(2):141.Google Scholar

Redmer, DA, Aitken, RP, Milne, JS, Reynolds, LP, Wallace, JM. Influence of maternal nutrition on messenger RNA expression of placental angiogenic factors and their receptors at midgestation in adolescent sheep. Biol Reprod 2005;72(4):1004–9.Google Scholar

Redmer, DA, Luther, JS, Milne, JS, Aitken, RP, Johnson, ML, Borowicz, PP, et al. Fetoplacental growth and vascular development in overnourished adolescent sheep at day 50, 90 and 130 of gestation. Reproduction 2009;137(4):749–57.Google Scholar

Lea, RG, Wooding, P, Stewart, I, Hannah, LT, Morton, S, Wallace, K, et al. The expression of ovine placental lactogen, StAR and progesterone-associated steroidogenic enzymes in placentae of overnourished growing adolescent ewes. Reproduction 2007; 133(4):785–96.Google Scholar

Carr, DJ, Aitken, RP, Milne, JS, David, AL, Wallace, JM. Ultrasonographic assessment of growth and estimation of birthweight in late gestation fetal sheep. Ultrasound Med Biol 2011;37(10):1588–95.Google Scholar

Smith, GC, Smith, MF, McNay, MB, Fleming, JE. The relation between fetal abdominal circumference and birthweight: Findings in 3512 pregnancies. BJOG 1997;104(2):186–90.Google Scholar

Carr, DJ, Aitken, RP, Milne, JS, Peebles, DM, Martin, JM, Zachary, IC, et al. Prenatal Ad.VEGF gene therapy – a promising new treatment for fetal growth restriction. Hum Gene Ther 2011;22(10):A128.Google Scholar

Carr, DJ, Aitken, RP, Milne, JS, Peebles, DM, Martin, JM, Zachary, IC, et al. Maternal delivery of Ad.VEGF gene therapy increases fetal growth velocity in an ovine paradigm of fetal growth restriction. Reprod Sci 2011; 18(3 suppl):269A.Google Scholar

Carr, DJ, Aitken, RP, Milne, JS, Peebles, DM, Martin, JM, Zachary, IC, et al. Alterations in postnatal growth and metabolism following prenatal treatment of intrauterine growth restriction with Ad.VEGF gene therapy in the sheep. Arch Dis Child Fetal Neonatal Ed 2011;96:Fa7.Google Scholar

Carr, DJ, Aitken, RP, Milne, JS, Peebles, DM, Martin, JF, Zachary, IC, et al. Prenatal gene therapy increases fetal growth velocity and expression of VEGF receptors in an ovine paradigm of fetal growth restriction. Reprod Sci 2012;19(3):78A.Google Scholar

Carter, AM. Animal models of human placentation – a review. Placenta 2007;28 Suppl A:S41–7.Google Scholar

Mess, A. The Guinea pig placenta: Model of placental growth dynamics. Placenta 2007;28(8–9):812–15.Google Scholar

Roberts, CT, Sohlstrom, A, Kind, KL, Earl, RA, Khong, TY, Robinson, JS, et al. Maternal food restriction reduces the exchange surface area and increases the barrier thickness of the placenta in the guinea-pig. Placenta 2001;22(2–3):177–85.Google Scholar

Mehta, V, Boyd, M, Martin, J, Zachary, I, Peebles, DM, David, AL. Local administration of Ad.VEGF-A165 to the uteroplacental circulation enhances fetal growth and reduces brain sparing in an FGR model of guinea pig pregnancy. Reprod Sci 2012;19(3):78A.Google Scholar

Sferruzzi-Perri, AN, Owens, JA, Pringle, KG, Robinson, JS, Roberts, CT. Maternal insulin-like growth factors-I and -II act via different pathways to promote fetal growth. Endocrinology 2006;147(7):3344–55.Google Scholar

Sferruzzi-Perri, AN, Owens, JA, Standen, P, Taylor, RL, Heinemann, GK, Robinson, JS, et al. Early treatment of the pregnant guinea pig with IGFs promotes placental transport and nutrient partitioning near term. Am J Physiol Endocrinol Metab 2007;292(3):E668–76.Google Scholar

Sohlstrom, A, Fernberg, P, Owens, JA, Owens, PC. Maternal nutrition affects the ability of treatment with IGF-I and IGF-II to increase growth of the placenta and fetus, in guinea pigs. Growth Horm IGF Res 2001; 11(6):392–8.Google Scholar

Eremia, SC, de Boo, HA, Bloomfield, FH, Oliver, MH, Harding, JE. Fetal and amniotic insulin-like growth factor-I supplements improve growth rate in intrauterine growth restriction fetal sheep. Endocrinology 2007;148(6):2963–72.Google Scholar

Wali, JA, de Boo, HA, Derraik, JG, Phua, HH, Oliver, MH, Bloomfield, FH, et al. Weekly intra-amniotic IGF-1 treatment increases growth of growth-restricted ovine fetuses and up-regulates placental amino acid transporters. PloS One 2012;7(5):e37899.Google Scholar

Miller, AG, Aplin, JD, Westwood, M. Adenovirally mediated expression of insulin-like growth factors enhances the function of first trimester placental fibroblasts. J Clin Endocrinol Metab 2005; 90(1):379–85.Google Scholar

Jones, H, Crombleholme, T, Habli, M. Regulation of amino acid transporters by adenoviral-mediated human insulin-like growth factor-1 in a mouse model of placental insufficiency in vivo and the human trophoblast line BeWo in vitro. Placenta 2014; 35(2):132–8.Google Scholar

Jones, HN, Crombleholme, T, Habli, M. Adenoviral-mediated placental gene transfer of IGF-1 corrects placental insufficiency via enhanced placental glucose transport mechanisms. PloS One 2013;8(9):e74632.Google Scholar

Habli, M, Jones, H, Aronow, B, Omar, K, Crombleholme, TM. Recapitulation of characteristics of human placental vascular insufficiency in a novel mouse model. Placenta 2013;34(12):1150–8.Google Scholar

David, AL, Ashcroft, R. Placental gene therapy. Obstet Gynaecol Reprod Med 2009;19(10):296–8.Google Scholar

Sheppard, MK, Spencer, RN, David, AL, Ashcroft, R. Evaluation of the ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early-onset fetal growth restriction in pregnant women. Hum Gene Ther 2014:A98.Google Scholar

Hedman, M, Muona, K, Hedman, A, Kivela, A, Syvanne, M, Eranen, J, et al. Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer. Gene Ther 2009; 16(5):629–34.Google Scholar

Rosengart, TK, Bishawi, MM, Halbreiner, MS, Fakhoury, M, Finnin, E, Hollmann, C, et al. Long-term follow-up assessment of a phase 1 trial of angiogenic gene therapy using direct intramyocardial administration of an adenoviral vector expressing the VEGF121 cDNA for the treatment of diffuse coronary artery disease. Hum Gene Ther 2013;24(2):203–8.Google Scholar

Heikkila, A, Hiltunen, MO, Turunen, MP, Keski-Nisula, L, Turunen, AM, Rasanen, H, et al. Angiographically guided utero-placental gene transfer in rabbits with adenoviruses, plasmid/liposomes and plasmid/polyethyleneimine complexes. Gene Ther 2001; 8(10):784–8.Google Scholar

Brownbill, P, Desforges, M, Sebire, N, Greenwood, S, Sibley, CP, David, A. Human placental ex vivo studies to support an adenovirus-mediated vascular endothelial growth factor (VEGF) gene medicine for the treatment of severe early onset fetal growth restriction (FGR). Hum Gene Ther 2014;25(11):A60.Google Scholar

Woo, YJ, Raju, GP, Swain, JL, Richmond, ME, Gardner, TJ, Balice-Gordon, RJ. In utero cardiac gene transfer via intraplacental delivery of recombinant adenovirus. Circulation 1997;96(10):3561–9.Google Scholar

Turkay, A, Saunders, T, Kurachi, K. Intrauterine gene transfer: Gestational stage-specific gene delivery in mice. Gene Ther 1999;6(10):1685–94.Google Scholar

Xing, A, Boileau, P, Cauzac, M, Challier, JC, Girard, J, Hauguel-de Mouzon, S. Comparative in vivo approaches for selective adenovirus-mediated gene delivery to the placenta. Hum Gene Ther 2000; 11(1):167–77.Google Scholar

Senoo, M, Matsubara, Y, Fujii, K, Nagasaki, Y, Hiratsuka, M, Kure, S, et al. Adenovirus-mediated in utero gene transfer in mice and guinea pigs: tissue distribution of recombinant adenovirus determined by quantitative TaqMan-polymerase chain reaction assay. Mol Genet Metab 2000;69(4):269–76.Google Scholar

Katz, AB, Keswani, SG, Habli, M, Lim, FY, Zoltick, PW, Midrio, P, et al. Placental gene transfer: Transgene screening in mice for trophic effects on the placenta. Am J Obstet Gynecol 2009;201(5):499.e1–8.Google Scholar

Mehta, V, Peebles, DM, Boyd, M, Zachary, I, Martin, J, David, AL. Gene targeting to the utero-placental circulation of pregnant guinea pigs. Society for Gynaecologic Investigation 58th Annual Meeting: Reproductive Sciences; 2011. p. 332A.Google Scholar

Mok, M, Heidemann, B, Dundas, K, Gillespie, I, Clark, V. Interventional radiology in women with suspected placenta accreta undergoing caesarean section. Int J Obstet Anesth 2008;17(3):255–61.Google Scholar

Carnevale, FC, Kondo, MM, de Oliveira Sousa, W, Jr., Santos, AB, da Motta Leal Filho, JM, Moreira, AM, et al. Perioperative temporary occlusion of the internal iliac arteries as prophylaxis in cesarean section at risk of hemorrhage in placenta accreta. Cardiovasc Intervent Radiol 2011;34(4):758–64.Google Scholar

Alfirevic, Z, Sundberg, K, Brigham, S. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev 2003(3):CD003252.Google Scholar

Wing, DA, Powers, B, Hickok, D. U.S. Food and Drug Administration drug approval: Slow advances in obstetric care in the United States. Obstet Gynecol 2010;115(4):825–33.Google Scholar

European Medicines Agency. Guideline on the Non-clinical Studies Required before First Clinical Use of Gene Therapy Medicinal Products (EMEA/CHMP/GTWP/125459/2006). London: European Medicines Agency; 2008.Google Scholar

European Medicines Agency. ICH Harmonised Tripartite Guideline E6: Note for Guidance on Good Clinical Practice (PMP/ICH/135/95). London: European Medicines Agency; 2002.Google Scholar

European Medicines Agency. Detection of Toxicity to Reproduction for Medicinal Products and Toxicity to Male Fertility (CPMP/ICH/386/95). London: European Medicines Agency; 1994.Google Scholar